Reports

Sale

Hypoglossal Nerve Stimulation Therapy Market

Global Hypoglossal Nerve Stimulation Therapy Market Size, Share, Analysis, Outlook, Forecast: By Treatment Devices: Aura 6000 Sleep Therapy System, Others; By Product Type; By Distribution Channel; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032

Global Hypoglossal Nerve Stimulation Therapy Market Outlook

The global market for hypoglossal nerve stimulation therapy is expected to grow at a CAGR of about 13.2% in the forecast period of 2024-2032, owing to the rise in the prevalence of sleep disorders.

 

hypoglossal-nerve-stimulation-therapy-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Hypoglossal Nerve Stimulation Therapy

North America is expected to dominate the hypoglossal nerve stimulation therapy market in the forecast period. Major factors such as changes in lifestyle, rise in obstructive sleep apnea (OSA), high OSA-associated disease burden, favourable reimbursement policies, strong clinical pipeline, rising stress level, growing investments in the healthcare industry, and quick adoption of technology are expected to propel the market growth. Sleep disorders, especially sleep apnea, have emerged as a major public health concern in the United States. An estimated 22 million Americans suffer from sleep apnea, with 80 percent of moderate and severe obstructive sleep apnea cases going untreated . The low awareness regarding obstructive sleep apnea (OSA) and underdiagnosed cases represent a significant market development opportunity for the key players in the region.

Moreover, due to the high prevalence of sleep disorders in the United States, the government and non-government organisations are conducting campaigns to raise general awareness among people suffering from these disorders. This is likely to support the hypoglossal nerve stimulation therapy market in the country.

 

Market Segmentations

The hypoglossal nerve stimulator is a medical device that is implanted and electrically stimulates the hypoglossal nerve, causing tongue movement. This stimulation is timed to coincide with breathing in order to reduce upper airway blockage. The hypoglossal nerve stimulation system is totally implanted beneath the skin and is operated by a remote, allowing patients to sleep without thinking about devices on their face or in their mouth. Hypoglossal nerve stimulation (HGNS) is a novel technique for treating moderate to severe OSA in patients who cannot tolerate CPAP therapy.

The various treatment devices in the market are:

  • Aura 6000 Sleep Therapy System
  • Inspire II Upper Airway Stimulation Device
  • Others

Based on product type, the market is divided into:

  • Battery Free
  • Leadless
  • Implantable
  • Electrodes
  • Others

The several distribution channels of the market are:

  • Hypermarkets and Supermarkets
  • Pharmacies and Drug Stores
  • Online
  • Others

The regional markets for hypoglossal nerve stimulation therapy can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

hypoglossal-nerve-stimulation-therapy-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Obstructive Sleep Apnea Propelling the Market Growth

The growing incidence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a serious sleep disorder that increases the risk of fatal accidents or other health-related consequences caused by disrupted sleep, necessitates the global hypoglossal nerve stimulation therapy market. Hypoglossal neurostimulation devices are a relatively new, minimally sophisticated option and an innovative technique for treating obstructive sleep apnea. These devices aid in restoring the tone of the upper airway dilator muscle, hence reducing airway blockage. These devices are anticipated to provide lucrative opportunities to the market over the forecast period.

Further, the increase in chronic diseases, rise in geriatric population, growing research and development activities, along with technological advancements such as miniaturisation and automation, among others, are positively influencing the growth of the market during the forecast period. Favourable reimbursement scenarios related to implantation procedures in these facilities will further drive the market growth globally. Rising focus on operational efficiency, short stay, and highly efficient healthcare professionals will foster the market revenue. Other factors expected to fuel the market expansion during the forecast period include increasing healthcare expenditure, increasing awareness of the disorder and accessible treatment choices, which will lead to early diagnosis.

 

Key Players in the Global Market for Hypoglossal Nerve Stimulation Therapy

The report gives a detailed analysis of the following key players in the global hypoglossal nerve stimulation therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Nyxoah SA.
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Braebon Medical Corporation
  • Oventus Medical USA, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Devices
  • Product Type
  • Distribution Channel
  • Region
Breakup by Treatment Devices
  • Aura 6000 Sleep Therapy System
  • Inspire II Upper Airway Stimulation Device
  • Others
Breakup by Product Type
  • Battery Free
  • Leadless
  • Implantable
  • Electrodes
  • Others
Breakup by Distribution Channel
  • Hypermarkets and Supermarkets
  • Pharmacies and Drug Stores
  • Online
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Nyxoah SA.
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Braebon Medical Corporation
  • Oventus Medical USA, Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Hypoglossal Nerve Stimulation Therapy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Hypoglossal Nerve Stimulation Therapy Historical Market (2018-2023) 
    8.3    Global Hypoglossal Nerve Stimulation Therapy Market Forecast (2024-2032)
    8.4    Global Hypoglossal Nerve Stimulation Therapy Market by Treatment Devices
        8.4.1    Aura 6000 Sleep Therapy System
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Inspire II Upper Airway Stimulation Device
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Others
    8.5    Global Hypoglossal Nerve Stimulation Therapy Market by Product Type
        8.5.1    Battery Free
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Leadless
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Implantable
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Electrodes
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Others
    8.6    Global Hypoglossal Nerve Stimulation Therapy Market by Distribution Channel
        8.6.1    Hypermarkets and Supermarkets
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Pharmacies and Drug Stores
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Online
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Others    
    8.7    Global Hypoglossal Nerve Stimulation Therapy Market by Region
        8.7.1    North America
            8.7.1.1    Historical Trend (2018-2023) 
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Europe
            8.7.2.1    Historical Trend (2018-2023) 
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Asia Pacific
            8.7.3.1    Historical Trend (2018-2023) 
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Latin America
            8.7.4.1    Historical Trend (2018-2023) 
            8.7.4.2    Forecast Trend (2024-2032)
        8.7.5    Middle East and Africa
            8.7.5.1    Historical Trend (2018-2023) 
            8.7.5.2    Forecast Trend (2024-2032)
9    North America Hypoglossal Nerve Stimulation Therapy Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Hypoglossal Nerve Stimulation Therapy Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Hypoglossal Nerve Stimulation Therapy Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Hypoglossal Nerve Stimulation Therapy Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Hypoglossal Nerve Stimulation Therapy Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Nyxoah SA.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Fisher & Paykel Healthcare Limited
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Invacare Corporation
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Braebon Medical Corporation
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5   Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Hypoglossal Nerve Stimulation Therapy Market: Key Industry Highlights, 2017 and 2021
2.    Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Treatment Devices (USD Million), 2018-2023
3.    Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Treatment Devices (USD Million), 2024-2032
4.    Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Product Type (USD Million), 2018-2023
5.    Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Product Type (USD Million), 2024-2032
6.    Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
7.    Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
8.    Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Region (USD Million), 2018-2023
9.    Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Region (USD Million), 2024-2032
10.    North America Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2018-2023
11.    North America Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Europe Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Europe Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Asia Pacific Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Asia Pacific Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Latin America Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Latin America Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Middle East and Africa Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2018-2023
19.    Middle East and Africa Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Global Hypoglossal Nerve Stimulation Therapy Market Structure

Key Questions Answered in the Report

The global market for hypoglossal nerve stimulation therapy is projected to grow at a CAGR of 13.2% between 2024 and 2032.

The major drivers of the market include the increase in chronic diseases, rise in geriatric population, growing research and development activities, technological advancements, favourable reimbursement scenarios, and increasing healthcare expenditure.

The growing incidence of sleep deprivation disorders such as obstructive sleep apnea and increasing awareness of the disorder are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The various treatment devices in the market are aura 6000 sleep therapy system and inspire II upper airway stimulation device, among others.

Based on product type, the market is divided into battery free, leadless, implantable, and electrodes, among others.

The several distribution channels of the market are hypermarkets and supermarkets, pharmacies and drug stores, and online, among others.

The major players in the industry are Nyxoah SA., Fisher & Paykel Healthcare Limited, Invacare Corporation, Braebon Medical Corporation, and Oventus Medical USA, Inc., among others.

Analyst Review

The global hypoglossal nerve stimulation therapy market was driven by the growing incidence of sleep deprivation disorders, such as obstructive sleep apnea, in the historical period. Aided by the favourable reimbursement scenarios and increasing awareness of the disorder, the market is expected to grow at a CAGR of 13.2% in the forecast period of 2024-2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The various treatment devices in the market are aura 6000 sleep therapy system and inspire II upper airway stimulation device, among others. Based on product type, the market is divided into battery free, leadless, implantable, and electrodes, among others. The several distribution channels of the market are hypermarkets and supermarkets, pharmacies and drug stores, and online, among others. The major regional markets for hypoglossal nerve stimulation therapy are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the above market are Nyxoah SA., Fisher & Paykel Healthcare Limited, Invacare Corporation, Braebon Medical Corporation, and Oventus Medical USA, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER